Optimizing Investments; Concept to Market
June 15, 2010Tel Aviv, Israel - David Intercontinental Hotel - Hall D
1600hrs - 1800hrs
This educational workshop will provide information on optimising your investment through the proof of concept drug development model and will help you make the best decisions when it comes to dealing with the FDA and the EMEA.
Speakers and agenda
Chairperson: Opening Comments
Noga Bousso, Senior Manager GRO, OSM/GMBA Israel, PAREXEL International
Proof of Concept: Development Strategy
Partha Ghosh, Director and Service Lead, PAREXEL International
Operational Implementation of Proof of Concept model
Debbie Harper, Director, Operations, Early Product Development, PAREXEL International
A Global Perspective on MAA Procedures: EMEA / FDA Differences
Carrol Marcus, Vice President, PAREXEL International
PAREXEL Speakers Bureau
PAREXEL is your reliable source for knowledgeable speakers on issues affecting the pharmaceutical, biological, and medical device industries.
In addition to being leading subject matter experts, members of the PAREXEL team are experienced at delivering lively and compelling presentations to a broad range of audiences. If you need a speaker for an upcoming event, please click here.